Literature DB >> 24549810

Role of PACAP in migraine headaches.

László Vécsei1, Bernadett Tuka, János Tajti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24549810     DOI： 10.1093/brain/awu014

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  9 in total

1.  Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.

Authors:  Anne-Sophie Wattiez; Levi P Sowers; Andrew F Russo
Journal:  Expert Opin Ther Targets       Date:  2020-02-13       Impact factor: 6.902

Review 2.  Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine.

Authors:  Anne Luise Haulund Vollesen; Faisal Mohammad Amin; Messoud Ashina
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 3.  Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update.

Authors:  János Tajti; Délia Szok; Anett Csáti; László Vécsei
Journal:  Curr Pain Headache Rep       Date:  2016-01

4.  Circulating PACAP peptide and PAC1R genotype as possible transdiagnostic biomarkers for anxiety disorders in women: a preliminary study.

Authors:  Rachel A Ross; Susanne S Hoeppner; Samantha N Hellberg; Emily B O'Day; Peter L Rosencrans; Kerry J Ressler; Víctor May; Naomi M Simon
Journal:  Neuropsychopharmacology       Date:  2020-01-07       Impact factor: 8.294

Review 5.  Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety.

Authors:  Délia Szok; Anett Csáti; László Vécsei; János Tajti
Journal:  Toxins (Basel)       Date:  2015-07-17       Impact factor: 4.546

6.  Release of PACAP-38 in episodic cluster headache patients - an exploratory study.

Authors:  Bernadett Tuka; Nikoletta Szabó; Eszter Tóth; Zsigmond Tamás Kincses; Árpád Párdutz; Délia Szok; Tamás Körtési; Teréz Bagoly; Zsuzsanna Helyes; Lars Edvinsson; László Vécsei; János Tajti
Journal:  J Headache Pain       Date:  2016-07-30       Impact factor: 7.277

7.  Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson's disease focusing on correlations with motor symptoms.

Authors:  Daniel Pham; Beata Polgar; Tunde Toth; Adel Jungling; Norbert Kovacs; Istvan Balas; Endre Pal; Dora Szabo; Balazs Daniel Fulop; Dora Reglodi; Zalan Szanto; Robert Herczeg; Attila Gyenesei; Andrea Tamas
Journal:  Geroscience       Date:  2022-02-26       Impact factor: 7.581

8.  Kynurenic Acid Inhibits the Electrical Stimulation Induced Elevated Pituitary Adenylate Cyclase-Activating Polypeptide Expression in the TNC.

Authors:  Tamás Körtési; Bernadett Tuka; János Tajti; Teréz Bagoly; Ferenc Fülöp; Zsuzsanna Helyes; László Vécsei
Journal:  Front Neurol       Date:  2018-01-16       Impact factor: 4.003

9.  Association of Intranasal and Neurogenic Dural Inflammation in Experimental Acute Rhinosinusitis.

Authors:  Luka Lovrenčić; Ivica Matak; Zdravko Lacković
Journal:  Front Pharmacol       Date:  2020-10-15       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.